脳卒中診断と治療の世界市場2016-2022

【英語タイトル】Stroke Diagnostics and Therapeutics - Global Market Outlook (2016-2022)

Stratistics MRCが出版した調査資料(SMRC70207136)・商品コード:SMRC70207136
・発行会社(調査会社):Stratistics MRC
・発行日:2017年1月
・ページ数:180
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥468,950見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥593,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、脳卒中診断と治療の世界市場について調査・分析し、脳卒中診断と治療の世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
- エグゼクティブサマリー
- 序文
- 脳卒中診断と治療の世界市場:市場動向分析
- 脳卒中診断と治療の世界市場:競争要因分析
- 脳卒中診断と治療の世界市場:種類別
・診断
・治療
- 脳卒中診断と治療の世界市場:用途別
・脳出血
・虚血性発作
- 脳卒中診断と治療の世界市場:主要地域別分析
- 脳卒中診断と治療の北米市場規模(アメリカ市場等)
- 脳卒中診断と治療のヨーロッパ市場規模
- 脳卒中診断と治療のアジア市場規模(日本市場、中国市場、インド市場等)
・脳卒中診断と治療の世界市場:主な市場開拓
- 関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Stroke Diagnostics and Therapeutics market is accounted for $21.6 billion in 2015 and is expected to reach $35.6 billion by 2022 growing at a CAGR of 7.3% from 2015 to 2022. Factors such as technological advancement, growing aging population, and people suffering from diabetes, increasing health expenditure, hypertension and also increasing tobacco users will boost the market growth. However, factors such as unfavorable reimbursement scenario and high cost of treatments are restraining the market growth.
North America commanded the largest market due to technologically advanced equipment for the diagnosis and improved healthcare infrastructure in this region. Asia Pacific is anticipated to witness fastest growth rate during the forecast period due to ongoing R&D activities for drug discovery and development and increasing government initiative in funding.
Some of the key players in global Stroke Diagnostics and Therapeutics market are Abbott Laboratories, Siemens AG, Stryker Corporation, GE Healthcare, Medtronic plc, Cordis Corporation, Genentech Inc., Boston Scientific Corporation, Coaxia Inc and Philips Healthcare.
Types Covered:
• Diagnostics
o Magnetic Resonance Imaging (MRI)
o Computed Tomography Scan (CT scan)
o Electrocardiography
o Carotid Ultrasound
o Others
• Therapeutics
o Tissue Plasminogen Activator
o Antiplatelet
o Antihypertensive
o Anticoagulant
Applications Covered:
• Haemorrhagic Stroke
• Ischemic Stroke
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Stroke Diagnostics and Therapeutics Market, By Type
5.1 Diagnostics
5.1.1 Magnetic Resonance Imaging (MRI)
5.1.2 Computed Tomography Scan (CT scan)
5.1.3 Electrocardiography
5.1.4 Carotid Ultrasound
5.1.5 Others
5.2 Therapeutics
5.2.1 Tissue Plasminogen Activator
5.2.2 Antiplatelet
5.2.3 Antihypertensive
5.2.4 Anticoagulant

6 Global Stroke Diagnostics and Therapeutics Market, By Application
6.1 Introduction
6.2 Haemorrhagic Stroke
6.3 Ischemic Stroke

7 Global Stroke Diagnostics and Therapeutics Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.7 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.7 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Abbott Laboratories
9.2 Siemens AG
9.3 Stryker Corporation
9.4 GE Healthcare
9.5 Medtronic plc
9.6 Cordis Corporation
9.7 Genentech Inc.
9.8 Boston Scientific Corporation
9.9 Coaxia Inc
9.10 Philips Healthcare

List of Tables
Table 1 Global Stroke Diagnostics and Therapeutics Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Stroke Diagnostics and Therapeutics Market Outlook, By Type (2013-2022) ($MN)
Table 3 Global Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 4 Global Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 5 Global Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2013-2022) ($MN)
Table 6 Global Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2013-2022) ($MN)
Table 7 Global Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2013-2022) ($MN)
Table 8 Global Stroke Diagnostics and Therapeutics Market Outlook, By Others (2013-2022) ($MN)
Table 9 Global Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 10 Global Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2013-2022) ($MN)
Table 11 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2013-2022) ($MN)
Table 12 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2013-2022) ($MN)
Table 13 Global Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2013-2022) ($MN)
Table 14 Global Stroke Diagnostics and Therapeutics Market Outlook, By Application (2013-2022) ($MN)
Table 15 Global Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2013-2022) ($MN)
Table 16 Global Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2013-2022) ($MN)
Table 17 North America Stroke Diagnostics and Therapeutics Market Outlook, By Country (2013-2022) ($MN)
Table 18 North America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2013-2022) ($MN)
Table 19 North America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 20 North America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 21 North America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2013-2022) ($MN)
Table 22 North America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2013-2022) ($MN)
Table 23 North America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2013-2022) ($MN)
Table 24 North America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2013-2022) ($MN)
Table 25 North America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 26 North America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2013-2022) ($MN)
Table 27 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2013-2022) ($MN)
Table 28 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2013-2022) ($MN)
Table 29 North America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2013-2022) ($MN)
Table 30 North America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2013-2022) ($MN)
Table 31 North America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2013-2022) ($MN)
Table 32 North America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2013-2022) ($MN)
Table 33 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Country (2013-2022) ($MN)
Table 34 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Type (2013-2022) ($MN)
Table 35 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 36 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 37 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2013-2022) ($MN)
Table 38 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2013-2022) ($MN)
Table 39 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2013-2022) ($MN)
Table 40 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Others (2013-2022) ($MN)
Table 41 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 42 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2013-2022) ($MN)
Table 43 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2013-2022) ($MN)
Table 44 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2013-2022) ($MN)
Table 45 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2013-2022) ($MN)
Table 46 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Application (2013-2022) ($MN)
Table 47 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2013-2022) ($MN)
Table 48 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2013-2022) ($MN)
Table 49 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Country (2013-2022) ($MN)
Table 50 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Type (2013-2022) ($MN)
Table 51 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 52 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 53 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2013-2022) ($MN)
Table 54 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2013-2022) ($MN)
Table 55 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2013-2022) ($MN)
Table 56 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Others (2013-2022) ($MN)
Table 57 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 58 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2013-2022) ($MN)
Table 59 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2013-2022) ($MN)
Table 60 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2013-2022) ($MN)
Table 61 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2013-2022) ($MN)
Table 62 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Application (2013-2022) ($MN)
Table 63 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2013-2022) ($MN)
Table 64 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2013-2022) ($MN)
Table 65 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Country (2013-2022) ($MN)
Table 66 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Type (2013-2022) ($MN)
Table 67 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 68 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
Table 69 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2013-2022) ($MN)
Table 70 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2013-2022) ($MN)
Table 71 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2013-2022) ($MN)
Table 72 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Others (2013-2022) ($MN)
Table 73 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 74 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2013-2022) ($MN)
Table 75 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2013-2022) ($MN)
Table 76 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2013-2022) ($MN)
Table 77 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2013-2022) ($MN)
Table 78 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Application (2013-2022) ($MN)
Table 79 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2013-2022) ($MN)
Table 80 RoW Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2013-2022) ($MN)



★調査レポート[脳卒中診断と治療の世界市場2016-2022] (コード:SMRC70207136)販売に関する免責事項を必ずご確認ください。
★調査レポート[脳卒中診断と治療の世界市場2016-2022]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆